期刊文献+

胃癌组织中端粒酶活性与细胞周期蛋白D1表达关系的研究 被引量:2

A study of relationship between telomerase activity and cyclin D1 expression in gastric cancer tissue
下载PDF
导出
摘要 目的 探索胃癌组织中端粒酶可能的激活途径。方法 利用BoehringerMannhei公司TelomerasePCR ELISAKit测量端粒酶活性 ;利用RT PCRELISA检测细胞周期蛋白D1mRNA表达水平。共检测了 84例胃癌及其相关性的组织标本。统计分析利用STATISTICA/W 5 0软件进行。结果 周期蛋白D1异常高表达在胃良性疾病、胃癌前期病变和胃癌组织中均可检出。而端粒酶活性仅在胃癌前期病变和胃癌组织中检出。胃癌前期病变和胃癌组织中端粒酶活性与周期蛋白D1表达程度明显正相关 (r =0 .713,P <0 .0 5 ,n =5 0 )。 Objective To explore the possible way of telomerase acitvation and its clinical significance in human gastric cancer.Methods Telomerase activity was measured with Telomerase PCR ELISA Kit (Boehringer Mannhei).Cyclin D1 mRNA level was detected with Cyclin D1 RT PCR ELISA.The 84 tissue samples of primary gastric cancer and its associated cases were analyzed.Statistical correlation analysis and significant test were performed using STATISTICA/W5.0.Results The analysis of clinical sample displayed the progressing increase of Cyclin D1 overexpression level was found from gastric benign disease to precancerous lesion and gastric cancer.Howerver,telomerase activity was presented only at serious stage of precancerous lesion and gastric cancer.Moreover,correlation analysis revealed significant association between Cyclin D1 mRNA and telomerase activity level in tissue samples of precancerous lesion and gastric cancer( r =0.713, P <0.05, n =50).Conclusion At least in human gastric cancer,Cyclin D1 overexpression may be a way of telomerase activation.
出处 《重庆医学》 CAS CSCD 2003年第9期1144-1146,共3页 Chongqing medicine
基金 重庆市科技计划基金资助课题 (2 0 0 1 1 5 2 4 )
关键词 胃肿瘤 端粒 端粒酶 细胞周期蛋白 stomach neoplasm telomere telomerase cell cycle Cylin
  • 相关文献

参考文献3

二级参考文献2

  • 1陈兵,国外医学内科学分册,1996年,23卷,11期,485页
  • 2Jiang W,Oncogene,1993年,8卷,3447页

共引文献27

同被引文献32

  • 1尹家俊,胡祥,金礼吉,袁晓东,安利佳.反义人端粒酶逆转录酶基因转染对人胃癌细胞系的影响[J].中华胃肠外科杂志,2004,7(5):397-400. 被引量:2
  • 2陈陵,杨仕明,蔡永国,房殿春,李晶晶,罗元辉.针对端粒酶蛋白催化亚单位的肿瘤免疫治疗研究[J].世界华人消化杂志,2005,13(4):528-533. 被引量:16
  • 3Petri A, Lindow M, Kauppinen S. MicroRNA silencing in primates : towards development of novel therapeutics[J]. Cancer Res,2009,69(2) :393-395.
  • 4Herranz H,Cohen SM. MicroRNAs and gene regulatory networks:managing the impact of noise in biological sys- tems[J]. Genes Dev, 2010,24(13) : 1339-1344.
  • 5Artandi SE, Chang S, Lee SL, et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice [ J ].Nature ,2000,406(6796) :461 - 465.
  • 6Jady BE, Bertrand E, Kiss T. Human telomerase RNA and box H/ACA scaRNAs share a common Cajal body-specific localization signal[J]. J cell Bio1,2004,164(5) :647 - 652.
  • 7Bonder AG, Quellette M, Frolkis M, et al. Extension of life-span by introduction of telomerase into normal human cells[ J]. Science, 1998,279 (5349) : 349 - 352.
  • 8Yatabe N, Kyo S, Maida Y, et al. HIF-1-mediated activation of telomerase in cervical cancer cells[ J ]. Oncogene, 2004,23 (20) : 3708- 3715.
  • 9Li S, Crothers J, Haqq CM, et al. Cellular and gene expression responses involved in the rapid growth inhibition of human cancer cells by RNA interference-mediated depletion of telomerase RNA [ J ]. J Boil Chem ,2005,25( 1 ) :75 - 79.
  • 10Helder MN, Wisman GB, van-der-Zee GJ. Telomerase and telomeres:from basic biology to cancer treatment [ J ]. Cancer Invest, 2002, 20(1):82- 101.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部